Clinical Trial Update: PAD. ICORG 05-01, V11 [Phase 2]

View source ↗

Summary

Phase 2 trial ICORG 05-01 for multiple myeloma and plasma cell neoplasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED